Cargando…

New Food and Drug Administration Recommendations for Clozapine Prescribing and Monitoring Requirements

Detalles Bibliográficos
Autor principal:	Mohapatra, Satyakam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052970/ https://www.ncbi.nlm.nih.gov/pubmed/27833240 http://dx.doi.org/10.4103/0253-7176.191394

Ejemplares similares

Clozapine prescribing and safety during COVID-19
por: Wadoo, Ovais, et al.
Publicado: (2021)

THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES
por: Pfizer, N., et al.
Publicado: (2002)

Prescribing practices of clozapine in India: Results of a opinion survey of psychiatrists
por: Shrivastava, Amresh, et al.
Publicado: (2009)

IS MONITORING OF PLATELETS NECESSARY DURING CLOZAPINE THERAPY ?
por: Tharyan, Prathap
Publicado: (1999)

Combination of ECT and clozapine in drug-resistant schizophrenia
por: Kurian, S., et al.
Publicado: (2005)

Clozapine & constipation: an audit of bowel habit monitoring and laxative prescribing in inpatients on clozapine
por: Boyd, Holly, et al.
Publicado: (2021)

Neuropsychiatric manifestations in a child with moyamoya disease
por: Mohapatra, Satyakam, et al.
Publicado: (2016)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Clozapine Use in Adolescents
por: Praharaj, Samir Kumar
Publicado: (2017)

Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic
por: Grover, Sandeep, et al.
Publicado: (2020)

Clozapine: A friend estranged?
por: Agarwal, Mahavir, et al.
Publicado: (2011)

The Problem Schizophrenic : Clozapine or ECT?
por: Andrade, C.
Publicado: (1996)

AGRANULOCYTOSIS DURING CLOZAPINE THERAPY
por: Jagadheesan, K., et al.
Publicado: (2000)

Clozapine-induced Delayed Ejaculation
por: Das, Soumitra, et al.
Publicado: (2017)

Clozapine-induced Tardive Dyskinesia
por: Das, Soumitra, et al.
Publicado: (2017)

Expedited Development Programs at the Food and Drug Administration: Insights and Opportunities
por: Collins, Grace, et al.
Publicado: (2021)

Low-frequency monitoring for community clozapine initiations: A comparative study relative to standard frequency assessments
por: Mizuno, Yuya, et al.
Publicado: (2023)

CLOZAPINE FOR PSYCHOTIC AND BEHAVIOURAL PROBLEMS IN DEMENTIA
por: Srinivasan, T.N.
Publicado: (1999)

Clozapine Induced Supra Ventricular Tachycardia
por: Kirpekar, C. Vivek, et al.
Publicado: (2015)

Late-onset neutropenia due to clozapine
por: Tatar, Zeynep Baran, et al.
Publicado: (2015)

Clozapine Toxicity in the Setting of COVID-19
por: Dotson, Samuel, et al.
Publicado: (2020)

Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
por: Litwinowicz, Radoslaw, et al.
Publicado: (2017)

Mandatory certification for clozapine prescribing
por: Cohen, Dan, et al.
Publicado: (2020)

Alopecia Areata Monolocularis in Clozapine-induced Hypereosinophilia
por: Jha, Shailesh, et al.
Publicado: (2016)

Clozapine Induced Urinary Incontinence During Sleep
por: Bhirud, Mahesh, et al.
Publicado: (2004)

Meningomyelocele on Exposure to Clozapine During Perinatal Period
por: Narayanaswamy, Prakruthi, et al.
Publicado: (2019)

Clozapine-Related Constipation: A Retrospective Study
por: Grover, Sandeep, et al.
Publicado: (2019)

Clozapine withdrawal catatonia: A case report
por: Jagota, Gopika, et al.
Publicado: (2023)

Neuropsychiatric manifestations in a child with agenesis of the corpus callosum
por: Mohapatra, Satyakam, et al.
Publicado: (2015)

Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes
por: Norman, Jessica L, et al.
Publicado: (2017)

Tardive dyskinesia with clozapine dose reduction or withdrawal dyskinesia?
por: Praharaj, Samir Kumar
Publicado: (2011)

Aripiprazole as a treatment option for clozapine-induced enuresis
por: Palaniappan, Pradeep
Publicado: (2015)

Starting clozapine in patients with schizophrenia during the ongoing pandemic
por: Grover, Sandeep, et al.
Publicado: (2022)

Clozapine Monitoring in Clinical Practice: Beyond the Mandatory Requirement
por: Kar, Nilamadhab, et al.
Publicado: (2016)

A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels
por: Arrojo-Romero, Manuel, et al.
Publicado: (2022)

A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels
por: Arrojo-Romero, Manuel, et al.
Publicado: (2022)

Clozapine-induced esophagitis at therapeutic dose: a case report
por: Javelot, Hervé, et al.
Publicado: (2016)

NON RESPONSIVENESS TO ECT -- AN ADDITIONAL PRE-REQUISITE FOR CLOZAPINE THERAPY
por: Pandey, S.K.
Publicado: (1996)

Successful use of adjuvant raloxifene treatment in clozapine-resistant schizophrenia
por: Shivakumar, Venkataram, et al.
Publicado: (2012)

Clozapine induced eosinophilia: An often neglected important adverse effect
por: Kadiyala, Pavan Kumar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hqf29351se3hq3bcohsksm9pqj